| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 2823783 | Multiple Sclerosis and Related Disorders | 2016 | 4 Pages | 
Abstract
												We provide evidence that supports the validity of GLTEQ scores as measures of vigorous and MVPA in POMS. Researchers and clinicians might adopt this scale for measuring PA.
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Genetics
												
											Authors
												Dominique Kinnett-Hopkins, Stephanie A. Grover, E. Ann Yeh, Robert W. Motl, 
											